Home >  Medicine MDTV >  Medicine Shorts >  Continuous air way...

Continuous air way pressure reduces intubation in covid patients

By - Dr. Nandita Mohan
Published On 2022-01-29 11:29 GMT   |   Update On 2022-01-31 04:20 GMT
Advertisement

Covid-19 has taken millions of lives as it drops oxygen level in blood rapidly, and causes lung to collapse. Critical care is very crucial in patients affected with severe covid-19 symptoms.

Recent study was conducted to see if continuous positive airway pressure (CPAP) or  high-flow nasal oxygen (HFNO) improves clinical outcomes in hospitalized patients with COVID-19-related acute hypoxemic respiratory failure as compared to standard oxygen treatment. The findings of this study were published in the Journal of American Medical Association.

Advertisement

Study reported that an initial strategy of CPAP significantly reduced the risk of tracheal intubation or mortality compared to conventional oxygen therapy in patients with acute hypoxemic respiratory failure caused by COVID-19, but there was no significant difference between an initial strategy of HFNO and conventional oxygen therapy.


For more information check out the full story on the link below:

CPAP significantly reduces tracheal intubation risk in COVID-19 patients with respiratory failure: NEJM 

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Nandita Mohan

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

mRNA COVID vaccines may improve survival rates in cancer patients, Study shows

Reperfusion Therapy for STEMI in LMICs: A Clinical Consensus Discussion with Dr Thomas Alexander

Common cholesterol-lowering drugs may reduce risk of developing dementia: Study

Can Taking 4,000 Steps Just Once a Week Lower the Risk of Death and Heart Disease? Study Provides Clarity

Long-term Exercise Keeps Immune System Younger and Sharper: Study Finds

EASD 2025: First-Ever Guidelines Released to Address Diabetes Distress

DAa-ViNCI Study: Real-World Data shows Efficacy of Vildagliptin- Dapagliflozin FDC among High-CV Risk T2D in Indian Cardiology Settings

Rare Disease Show - Episode 26: Understanding Pfeiffer Syndrome ft Dr. Roshan Daniel